AzTrials
AzTrials

Sensorineural Hearing LossNCT04183361

ABR Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers

An observational study of Sensorineural Hearing Loss and Noise Induced Hearing Loss, run by University Hospital Sestre Milosrdnice at 1 site in Croatia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the research: Investigate the association of auditory evoked brainstem response characteristics with salivary cortisone concentrations in noise-exposed workers. Purpose of the research: 1. Investigate the magnitude of the amplitudes and latencies of auditory brainstem responses. 2. Read more about this study

Who is it for?
Ages 19 years and olderHealthy volunteers can take part
What is being tested?
ABR and salivary cortisone testing
How many people
100 participants
Where
1 siteCroatia
Study dates
1 Nov 2019to 1 Nov 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: An employer finds workers who meet points 1-5 of study inclusion criteria. A head of the research checks their medical history and includes them in the study if they do not meet any of first six exclusion criteria. A head of the research orally informs these workers at the meeting and helps them to understand and sign a written informed consent for participation in the research. Each of them receive an information about the date of arrival at the place of research and also a unique password that encodes saliva samples, completed questionnaires and electronic and printed findings derived from the assessment of hearing health.

Who may be able to join

  • male and female
  • ages 19-35
  • exposure to noise level ≥ 85 dB (A) per week at the workplace
  • work in noise from 1 to 16 years
  • workplace not involving exposure to carbon disulfide or a mixture of organic solvents that have toxic effects on the ear (toluene, xylene and styrene)
  • unilaterally or bilaterally normal otoscopic findings
  • unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with eardrum mobility of 0.3 to 1.3 mL

Who cannot join

  • information about an earlier sudden hearing loss
  • information on chronic middle ear inflammation
  • information on ear surgery (except placement of ventilation tubes in the eardrum)
  • information on dizziness associated with hearing loss and noise
  • information on insomnia
  • current use of oral corticosteroids
  • bilaterally found air-bone gap greater than 15 dB

Trial locations and contacts

1 site in 1 country.

Croatia1 site
  • University Hospital Center Sestre milosrdnice

    Zagreb, 10000

Other trials in Croatia

About this study

Official title: Correlation of Auditory Evoked Brainstem Response Characteristics and Salivary Cortisone Concentration in Noise-exposed Workers

The aim of the research:

Investigate the association of auditory evoked brainstem response characteristics with salivary cortisone concentrations in noise-exposed workers.

Read more

Purpose of the research:

  1. Investigate the magnitude of the amplitudes and latencies of auditory brainstem responses.
  2. Investigate the concentration of cortisone in saliva.
  3. To investigate the correlation of the characteristics of auditory evoked brainstem potentials with the age of the subjects or the length of work in noise.
  4. Investigate the association of salivary cortisone concentration with subjects' age or length of work in noise.
  5. Investigate the prevalence of mild, moderate and severe hearing impairment in the 19-35 age group.
  6. Investigate the relationship of hearing threshold shift with the age of the subjects or the length of work in noise.
  7. To investigate the difference in the characteristics of auditory evoked brainstem potentials and the difference in salivary cortisone concentration between subjects with a bilaterally normal hearing threshold (≤25 dB) at high frequencies and subjects with unilaterally or bilaterally increased hearing threshold (> 25 dB) at high frequencies .
  8. Investigate the perceived stress and psychosocial risk factors in the workplace and their relationship to salivary cortisone concentrations.

Research Hypothesis:

There is an association between the characteristics of auditory evoked brainstem response and salivary cortisone concentrations in noise-exposed workers.

Research participants

Inclusion criteria:

  1. male and female
  2. ages 19-35
  3. exposure to noise level ≥ 85 dB (A) per week at the workplace
  4. work in noise from 1 to 16 years
  5. workplace not involving exposure to carbon disulfide or a mixture of organic solvents that have toxic effects on the ear (toluene, xylene and styrene)
  6. unilaterally or bilaterally normal otoscopic findings
  7. unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with eardrum mobility of 0.3 to 1.3 mL

Exclusion criteria:

  1. information about an earlier sudden hearing loss
  2. information on chronic middle ear inflammation
  3. information on ear surgery (except placement of ventilation tubes in the eardrum)
  4. information on dizziness associated with hearing loss and noise
  5. information on insomnia
  6. current use of oral corticosteroids
  7. bilaterally found air-bone gap greater than 15 dB
Read the detailed description

The research is cross-sectional. The expected duration of the survey is at least 18 months. Assuming that the characteristics of the auditory evoked brainstem potentials are correlated with salivary cortisone concentration with a correlation coefficient of 0.4, a test power of 80% and a significance level of α = 0.05, at least 46 subjects should be included in the study. Test power analysis was performed using MedCalc Statistical Software, version 19.1 (MedCalc Software bv, Ostend, Belgium; https://www.medcalc.org; 2019). According to the data distribution (Kolmogorov-Smirnov test), appropriate parametric and / or non-parametric statistical tests will be applied in accordance with the obtained results. The data will be presented in tables and graphs. Numerical variables will be represented using the range, arithmetic mean and standard deviation, respectively, the median and the interquartile range, in cases of distribution that does not follow the normal distribution. The categorical variables will be presented using absolute frequencies and their respective proportions. Differences in the values of the numerical variables between the test groups with a defined hearing threshold will be analyzed by parametric Student's t-test for independent samples, and non-parametric Mann-Whitney U test for independent samples. Differences in categorical variables between the examined groups will be analyzed by chi-square test or Fisher's exact test in cases where the number of subjects in each group is less than 5. The corresponding correlation coefficients (Pearson's or Spearman's) between individual clinical variables will be calculated. An appropriate regression model for the prediction of belonging to a group with a defined hearing threshold shift will be made, which will include those that have a significance level of P≤0.20 in the previous statistical analyzes. In the above tests, significant P values will be considered to be less than 0.05. The statistical analysis of data will use IBM SPSS Statistics licensed software version 25.0.

Material:

  1. Audiometer Audiometer AC40
  2. DD45 audiometric headphones
  3. Interacoustics AZ26 tympanometer
  4. Equipment for testing auditory evoked brainstem potentials: ABR Interacoustics Eclipse, EPA Preamplifier, 3M E-A-RTONE Insert Earphone ABR
  5. Cortisol-Salivette Cotton Salad Carrier
  6. High Performance Liquid Chromatography (HPLC)
  7. validated questionnaire in the Croatian language - assessment of psychosocial risk factors in the HSE workplace 8th validated questionnaire in Croatian - The scale of stress experienced

Research plan:

An employer finds workers who meet points 1-5 of study inclusion criteria. A head of the research checks their medical history and includes them in the study if they do not meet any of first six exclusion criteria. A head of the research orally informs these workers at the meeting and helps them to understand and sign a written informed consent for participation in the research. Each of them receive an information about the date of arrival at the place of research and also a unique password that encodes saliva samples, completed questionnaires and electronic and printed findings derived from the assessment of hearing health. The research leader, research mentors, and occupational safety manager, who is responsible for supervising the sampling and storage of saliva samples in the refrigerator at +4 ℃ in the workplace, know the password and associated name.

A participant is expected to:

  1. Give three saliva samples at the workplace immediately after the morning shift. The first saliva sample was given 3 days (Tuesday) before arrival at the research place, the second sample 2 days (Wednesday) before arrival, and the third sample 1 day (Thursday) before arrival at the research site. One hour before saliva sampling, a respondent should not brush his/her teeth nor eat nor drink. Fifteen minutes prior to sample administration, the subject should rinse his/her mouth with a cold water. Then head of the research analyses coded saliva samples in laboratory by using High Performance Liquid Chromatography (HPLC) at the Translational Medicine Division of the Srebrnjak Children's Hospital. After processing and preparing each of the saliva samples for HPLC, the native sample no longer exists. After the analytes will be detected in the isolate, all the material will be completely eliminated as infectious waste.
  2. Collaboration in the process of assessing hearing health at the research place. The assessment includes: otoscopy, tympanometry and audiometry. Subjects who do not meet point 6 and 7 of the inclusion criteria or who meet point 7 of the exclusion criteria will not be tested for auditory evoked brainstem response. Other subjects will be tested for auditory evoked brainstem response in only one ear, with a more regular hearing threshold.
  3. Self-assessment of perceived stress and psychosocial risk factors in the workplace by completing a questionnaire at the research site.

A researcher conducting this research and the research participants will not receive a financial fee for their participation.

Expected scientific contribution of the research:

Quantification of the association of auditory evoked brainstem response characteristics with salivary cortisone concentrations among workers exposed to noise.

Possible risks of participating in the research:

This research involves no risk other than the usual daily risk.

Being tested
ABR and salivary cortisone testing
Keywords
noise, sensorineural hearing loss, ABR, cortisole, salivary
Medical subject headings
Hearing Loss, Sensorineural, Hearing Loss, Noise-Induced, Vestibulocochlear Nerve Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ABR and salivary cortisone testingDiagnostic test

    Three saliva samples at the workplace will be collected immediately after the morning shift. The first saliva sample was given 3 days (Tuesday) before arrival at the research place, the second sample 2 days (Wednesday) before arrival, and the third sample 1 day (Thursday) before arrival at the research site. One hour before saliva sampling, a respondent should not brush his/her teeth nor eat nor drink. Fifteen minutes prior to sample administration, the subject should rinse his/her mouth with a cold water. Samples will be analyzed using High Performance Liquid Chromatography (HPLC) at the Translational Medicine Division of the Srebrnjak Children's Hospital.

    1. Collaboration in the process of assessing hearing health at the research place. The assessment includes: otoscopy, tympanometry and audiometry. Subjects will be tested for auditory evoked brainstem response in only one ear, with a more regular hearing threshold.
Study groups in NCT04183361
Study groupRoleWhat they receive
Patients with noise exposure and salivary cortisone1. male and female 2. ages 19-35 3. exposure to noise level ≥ 85 dB (A) per week at the workplace 4. work in noise from 1 to 16 years 5. workplace not involving exposure to carbon disulfide or a mixture of organic solvents that have toxic effects on the ear (toluene, xylene and styrene) 6. unilaterally or bilaterally normal otoscopic findings 7. unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with eardrum mobility of 0.3 to 1.3 mL
Receives: Diagnostic Test: ABR and salivary cortisone testing
Patients without noise exposure and salivary cortisone1. male and female 2. ages 19-35 3. no exposure to noise level ≥ 85 dB (A) per week at the workplace 4. work in noise from 1 to 16 years 5. workplace not involving exposure to carbon disulfide or a mixture of organic solvents that have toxic effects on the ear (toluene, xylene and styrene) 6. unilaterally or bilaterally normal otoscopic findings 7. unilaterally or bilaterally tympanogram: peak pressure value ± 50 daPa at 226 Hz with eardrum mobility of 0.3 to 1.3 mL
Receives: Diagnostic Test: ABR and salivary cortisone testing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. auditory evoked brainstem response (ABR) characteristics

    auditory evoked brainstem response after noise exposure

    Measured: 1 day

  2. salivary cortisone concentration

    salivary cortisone concentration after noise exposure

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2019
  2. Study start1 Nov 2019
  3. Primary completion1 Nov 2020 (estimated)
  4. Study completion1 Nov 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04183361
Sponsor's protocol ID
EP-ABR01
Status last verified
Dec 2019
First submitted
27 Nov 2019
Last updated
5 Dec 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sensorineural Hearing Loss and Noise Induced Hearing Loss, run by University Hospital Sestre Milosrdnice at 1 site in Croatia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Dec 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Croatia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

auditory evoked brainstem response (ABR) characteristics (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in